OverviewChartNewsTraderScreen

DE000SN74AK4/  DE000SN74AK4  /

Frankfurt Zertifikate
10/01/2025  15:23:54 Chg.-0.010 Bid16:11:44 Ask16:11:44 Underlying Strike price Expiration date Option type
2.890EUR -0.34% 2.860
Bid Size: 35,000		 2.870
Ask Size: 35,000		 SANOFI SA INHABER ... 67.4512 EUR 31/12/2078 Call
TeleTrader 31/12/2024 Europe opens year-end session with losses
TeleTrader 22/11/2024 Europe closes higher, FTSE up over 1%
TeleTrader 25/10/2024 Europe closes mixed amid earnings, data
TeleTrader 25/10/2024 Europe lower in premarket as financial results pour in
TeleTrader 25/10/2024 Sanofi's Q3 net sales up by 15.7% to €13.44 billion
TeleTrader 21/10/2024 Sanofi in talks with CD&R for 50% stake in Opella
GlobeNewswire 02/09/2024 Press Release: Tolebrutinib meets primary endpoint in HERCULES phase 3 study, the first and only to ...
GlobeNewswire 26/08/2024 Latest Dupixent® (dupilumab) and Itepekimab Data at ERS Highlight Scientific Innovation and Leadersh...
GlobeNewswire 14/08/2024 Anaptys Announces Pricing of $100 Million Underwritten Registered Direct Offering
GlobeNewswire 13/08/2024 Vigil Neuroscience Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 12/08/2024 MeiraGTx Announces $50 Million Offering of Ordinary Shares led by Sanofi and Reports Second Quarter ...
GlobeNewswire 12/08/2024 MeiraGTx Announces Pricing of Offering of Ordinary Shares Led by Sanofi
GlobeNewswire 08/08/2024 Press Release: Sarclisa induction treatment demonstrated significantly improved progression-free sur...
GlobeNewswire 07/08/2024 Kymera Therapeutics Announces Second Quarter 2024 Financial Results and Provides a Business Update
GlobeNewswire 06/08/2024 Alzheimer's Disease Diagnostics & Therapeutics Market Driven by Use of Biomarkers and Advancing R&D ...
GlobeNewswire 05/08/2024 Fierce Biotech Names Recludix Pharma a “Fierce 15” Biotech Company of 2024
GlobeNewswire 02/08/2024 Madrigal Pharmaceuticals Appoints Shannon Kelley as General Counsel
GlobeNewswire 01/08/2024 Denali Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights
GlobeNewswire 01/08/2024 Regeneron Reports Second Quarter 2024 Financial and Operating Results
GlobeNewswire 31/07/2024 Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2...
GlobeNewswire 25/07/2024 Press Release: Online availability of Sanofi’s half-year financial report for 2024
TeleTrader 25/07/2024 Europe lower premarket as earnings pour in
TeleTrader 25/07/2024 Sanofi net sales up 7.8% to €10.7B in Q2
GlobeNewswire 25/07/2024 Press Release: Sanofi Q2 - strong performance with 10% sales growth; 2024 guidance upgraded
GlobeNewswire 24/07/2024 US Hematologists Express High Unmet Need in Treatments for Warm Autoimmune Hemolytic Anemia and Cold...